Table 3.
Clinical Characteristics in UNOS cohort
| Diabetes (+) (N=3873) | Diabetes (–) (N=2757) | P | |
|---|---|---|---|
| Age | 58.7 ± 7.2 | 56.4 ± 9.0 | 0.006 |
| Gender (Male) | 1909 (49.3%) | 1347 (48.9%) | 0.72 |
| Race (White) | 3097 (80.0%) | 2261 (82.0%) | <0.001 |
| Ascites | 0.006 | ||
| None | 813 (21.0%) | 612 (22.2%) | |
| Grade 1–2 | 2345 (60.6%) | 1727 (62.7%) | |
| Grade 3–4 | 713 (18.4%) | 417 (15.1%) | |
| Hepatic Encephalopathy | 0.008 | ||
| None | 1350 (34.9%) | 1074 (39.0%) | |
| Grade 1–2 | 2394 (61.8%) | 1603 (58.2%) | |
| Grade 3–4 | 127 (3.3%) | 79 (2.9%) | |
| INR | 1.3 ± 0.3 | 1.4 ± 0.4 | <0.001 |
| Albumin | 3.2 ± 0.6 | 3.1 ± 0.6 | <0.001 |
| Creatinine | 1.2 ± 0.9 | 1.1 ± 0.8 | <0.001 |
| Bilirubin | 2.1 ± 1.9 | 2.7 ± 2.5 | <0.001 |
| CTP score | 8.3 ± 1.7 | 8.6 ± 1.7 | <0.001 |
| MELD score | 13.9 ± 4.3 | 14.4 ± 4.5 | <0.001 |
| BMI, body mass index | 33.1 ± 5.4 | 32.9 ± 5.8 | 0.21 |
| Obesity (BMI≥ 30) | 2850 (73.7%) | 2020 (73.4%) | 0.76 |
| HCC | 191 | 100 |